Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Vaccines Wins Second Consecutive "Best Vaccine CMO Award" at AVEA 2023 2023-12-13 08:30
CARsgen Presents Updated Research Results on Zevor-cel at 2023 ASH Annual Meeting 2023-12-12 21:50
KOSMODE HEALTH SINGAPORE PTE LTD, CLINCHES "THE MOST TRANSFORMATIONAL COLLABORATION" 2023 SICC AWARDS IN PARTNERSHIP WITH NESTLÉ SINGAPORE AND NESTLÉ R&D CENTRE. 2023-12-12 20:00
Dizal Impresses with Its Differentiated Hematological Oncology Portfolio at 2023 ASH 2023-12-12 18:00
WuXi Biologics Named to 2023 Dow Jones Sustainability World Index 2023-12-12 17:00
Fertility Journey with Femometer Ring: Where Style Meets Precision in Ovulation Tracking 2023-12-12 14:26
MGI Wraps Up Inaugural the Future of Omics Research Summit 2023-12-12 11:09
Live from ASH 2023 | Ascentage Pharma Presents the First Dataset of Bcl-2 inhibitor Lisaftoclax in Patients with AML, Demonstrating Favorable Efficacy and Safety 2023-12-12 09:41
IASO Bio and Innovent Present New Data of FUCASO® (Equecabtagene Autoleucel) for Multiple Myeloma Patients in Oral Presentation at ASH 2023 2023-12-12 03:30
Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project 2023-12-11 22:30
Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments 2023-12-11 21:00
Yingli Pharma presents a pivotal Phase 2 study data evaluating linperlisib in relapsed or refractory peripheral T-cell lymphoma in an oral session at the American Society of Hematology 2023 Annual Meeting 2023-12-11 21:00
HanAll Biopharma's Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors 2023-12-11 20:00
Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC for Phase III Clinical Trial 2023-12-11 20:00
2023 SABCS | Laekna Reports Afuresertib Phase Ib Breast Cancer Study Results 2023-12-11 18:55
Live from ASH 2023 | Ascentage Pharma Presents Updated Data from US Study of Olverembatinib, Further Validating Encouraging Efficacy in Patients Resistant to Ponatinib or Asciminib 2023-12-11 13:30
Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3% 2023-12-11 13:14
MGI Expands Presence in Latin America with New Partnerships with Genos Médica and TCL Group 2023-12-11 11:26
Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery 2023-12-11 09:00
Dizal's Golidocitinib Pivotal Trial Demonstrates Superior and Durable Clinical Benefits for Patients with r/r PTCL in Oral Presentation at 2023 ASH 2023-12-10 18:00
1 58 59 60 61 62 800